Yingnan Ye

1.6k total citations
32 papers, 1.2k citations indexed

About

Yingnan Ye is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Yingnan Ye has authored 32 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 10 papers in Molecular Biology and 8 papers in Immunology. Recurrent topics in Yingnan Ye's work include Immune cells in cancer (7 papers), Chemokine receptors and signaling (5 papers) and Cancer Cells and Metastasis (4 papers). Yingnan Ye is often cited by papers focused on Immune cells in cancer (7 papers), Chemokine receptors and signaling (5 papers) and Cancer Cells and Metastasis (4 papers). Yingnan Ye collaborates with scholars based in China and United States. Yingnan Ye's co-authors include Jinpu Yu, Wenwen Yu, Pengpeng Liu, Feng Wei, Xiubao Ren, Xin-Xin Long, Junya Ning, Lijie Zhang, Pengpeng Liu and Pei Xiao and has published in prestigious journals such as PLoS ONE, Biomaterials and Hepatology.

In The Last Decade

Yingnan Ye

31 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yingnan Ye China 18 585 410 371 332 119 32 1.2k
Majid Shahbazi Iran 13 463 0.8× 227 0.6× 271 0.7× 161 0.5× 135 1.1× 72 1.1k
Yun Cui China 21 650 1.1× 140 0.3× 228 0.6× 409 1.2× 225 1.9× 57 1.2k
Akaitz Dorronsoro Spain 17 736 1.3× 320 0.8× 130 0.4× 312 0.9× 97 0.8× 22 1.5k
Khoa Nguyen United States 17 399 0.7× 172 0.4× 216 0.6× 167 0.5× 62 0.5× 38 976
Meixiang Yang China 20 495 0.8× 503 1.2× 204 0.5× 131 0.4× 75 0.6× 38 1.2k
Dapeng Wang United States 19 494 0.8× 571 1.4× 288 0.8× 111 0.3× 58 0.5× 44 1.4k
Wolfgang Baum Germany 21 795 1.4× 509 1.2× 416 1.1× 110 0.3× 79 0.7× 37 1.9k
Hao Qiu China 18 373 0.6× 139 0.3× 227 0.6× 178 0.5× 100 0.8× 75 935
Antonella Conforti Italy 17 356 0.6× 270 0.7× 208 0.6× 144 0.4× 96 0.8× 31 1.0k
Antonio Díez‐Juan Spain 21 1.1k 1.9× 202 0.5× 218 0.6× 567 1.7× 69 0.6× 38 1.9k

Countries citing papers authored by Yingnan Ye

Since Specialization
Citations

This map shows the geographic impact of Yingnan Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingnan Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingnan Ye more than expected).

Fields of papers citing papers by Yingnan Ye

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yingnan Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingnan Ye. The network helps show where Yingnan Ye may publish in the future.

Co-authorship network of co-authors of Yingnan Ye

This figure shows the co-authorship network connecting the top 25 collaborators of Yingnan Ye. A scholar is included among the top collaborators of Yingnan Ye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yingnan Ye. Yingnan Ye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lai, Hong‐Shiee, Yingnan Ye, Yiqing Chen, et al.. (2025). Radiomics-based correlation analysis of fetal brain MRI features and children’s neurodevelopmental outcomes in monochorionic twins. BMC Pregnancy and Childbirth. 25(1). 1040–1040.
2.
Ning, Junya, Yingnan Ye, Hongru Shen, et al.. (2024). Macrophage-coated tumor cluster aggravates hepatoma invasion and immunotherapy resistance via generating local immune deprivation. Cell Reports Medicine. 5(5). 101505–101505. 12 indexed citations
3.
Li, Shengnan, Han Xia, Zeyu Wang, et al.. (2023). Intratumoral microbial heterogeneity affected tumor immune microenvironment and determined clinical outcome of HBV-related HCC. Hepatology. 78(4). 1079–1091. 43 indexed citations
4.
Ye, Yingnan, et al.. (2023). Supply Chain Finance Assistance for Small and Medium-Sized Enterprises Using Cognitive Web Services. International Journal of e-Collaboration. 19(2). 1–22. 2 indexed citations
5.
Zhang, Rui, Lei Han, Xiao Zhang, et al.. (2022). Vasohibin 2 promotes lymphangiogenesis of lung squamous cell carcinoma through snail-dependent vascular endothelial growth factor-D (VEGF-D) signaling pathway. Annals of Translational Medicine. 10(2). 39–39. 4 indexed citations
6.
Zhang, Rui, Pengpeng Liu, Xiao Zhang, Yingnan Ye, & Jinpu Yu. (2021). Lin28A promotes the proliferation and stemness of lung cancer cells via the activation of mitogen-activated protein kinase pathway dependent on microRNA let-7c. Annals of Translational Medicine. 9(12). 982–982. 5 indexed citations
7.
Wang, Ke, et al.. (2021). A hereditary ovarian cancer family with rare pathogenic splicing mutation: Implications for variant interpretation. Cancer Genetics. 256-257. 127–130. 1 indexed citations
8.
Ye, Yingnan, Linxi Zhang, Anping Wang, et al.. (2020). Association of sleep duration with stroke, myocardial infarction, and tumors in a Chinese population with metabolic syndrome: a retrospective study. Lipids in Health and Disease. 19(1). 155–155. 16 indexed citations
9.
Zhang, Rui, Fan Zhang, Zeguo Sun, et al.. (2019). LINE-1 Retrotransposition Promotes the Development and Progression of Lung Squamous Cell Carcinoma by Disrupting the Tumor-Suppressor Gene FGGY. Cancer Research. 79(17). 4453–4465. 33 indexed citations
10.
11.
Ye, Yingnan, Linxi Zhang, Wenhua Yan, et al.. (2019). Self-reported sleep duration and daytime napping are associated with renal hyperfiltration and microalbuminuria in an apparently healthy Chinese population. PLoS ONE. 14(8). e0214776–e0214776. 18 indexed citations
12.
14.
Wang, Peng, Pei Xiao, Yingnan Ye, et al.. (2017). Rapid response of brain metastasis to crizotinib in a patient with KLC1-ALK fusion and MET gene amplification positive non-small cell lung cancer: a case report. Cancer Biology and Medicine. 14(2). 183–183. 18 indexed citations
15.
Jiang, Mengmeng, Jieying Chen, Wenwen Zhang, et al.. (2017). Interleukin-6 Trans-Signaling Pathway Promotes Immunosuppressive Myeloid-Derived Suppressor Cells via Suppression of Suppressor of Cytokine Signaling 3 in Breast Cancer. Frontiers in Immunology. 8. 1840–1840. 100 indexed citations
16.
Liu, Pengpeng, Rui Zhang, Wenwen Yu, et al.. (2017). FGF1 and IGF1-conditioned 3D culture system promoted the amplification and cancer stemness of lung cancer cells. Biomaterials. 149. 63–76. 32 indexed citations
17.
Chen, Jieying, Yingnan Ye, Pengpeng Liu, et al.. (2016). Suppression of T cells by myeloid-derived suppressor cells in cancer. Human Immunology. 78(2). 113–119. 68 indexed citations
18.
19.
Long, Xin-Xin, Yingnan Ye, Lijie Zhang, et al.. (2015). IL-8, a novel messenger to cross-link inflammation and tumor EMT via autocrine and paracrine pathways (Review). International Journal of Oncology. 48(1). 5–12. 127 indexed citations
20.
Ye, Yingnan, Pengpeng Liu, Yue Wang, et al.. (2014). Neurotensin, a Novel Messenger to Cross-Link Inflammation and Tumor Invasion via Epithelial-Mesenchymal Transition Pathway. International Reviews of Immunology. 35(4). 340–350. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026